TipRanks
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market
CLCS
Cell Source
RESEARCH TOOLSreports

Cell Source (CLCS) Income Statement

12 Followers

Cell Source Income Statement

Last quarter (Q4 2024), Cell Source's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Cell Source's net income was $-589.71K. See Cell Source’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.73M$ 3.85M$ 4.33M$ 4.17M$ 4.02M
Depreciation and Amortization
$ 0.00$ 0.00$ 52.82K$ 4.17M$ 4.02M
EBITDA
$ -2.73M$ -3.60M$ -4.22M$ 0.00$ -93.00K
Operating Income
$ -2.73M$ -3.85M$ -4.33M$ -4.17M$ -4.02M
Other Income/Expenses
$ -1.91M$ -922.55K$ -996.00K$ -992.00K$ -1.45M
Pretax Income
$ -4.64M$ -4.77M$ -5.32M$ -5.17M$ -5.47M
Net Income
$ -4.64M$ -4.77M$ -5.32M$ -5.17M$ -5.47M
Per Share Metrics
Basic EPS
$ -0.10$ -0.15$ -0.17$ -0.18$ -0.19
Diluted EPS
$ -0.10$ -0.15$ -0.17$ -0.18$ -0.19
Weighted Average Shares Outstanding
 54.36M 41.87M 37.79M 34.84M 28.12M
Weighted Average Shares Outstanding (Diluted)
 54.36M 41.87M 37.79M 34.84M 33.12M
Currency in USD

Cell Source Earnings and Revenue History